title: Embryonic genome activation events in buffalo (Bubalus bubalis) preimplantation embryos.
abstract: Embryonic genome activation (EGA) is the first major step towards successful initiation of preimplantation development, which culminates in the formation of implantation-competent embryos. EGA occurs at species-specific embryonic cell stages. In the present work, EGA was identified for buffalo embryos by studying the development rate of embryos in normal as well as imposed transcription block conditions, analyzing bromo-uridine triphosphate (BrUTP) incorporation rates as evidence of de novo transcription initiation, and studying the expression status of eukaryotic translation initiation factor 1A (eIF1A), U2 auxiliary splicing factor (U2AF), and polyadenylate polymerase (PAP) genes at different embryonic cell stages. Under normal, in vitro fertilization and culture conditions, about 26% and 17% of oocytes could reach morula and blastocyst stages, respectively, but no embryos could progress beyond 8-cell stages in presence of α-amanitin. Culturing embryos in the presence of BrUTP revealed a marked increase in its incorporation between 4- and 8-cell stages. All genes studied displayed an abrupt increase in expression between 4- and 8-cell stages; PAP expression was upregulated earlier from 2- to 4-cell stages. About 65% of PAP transcripts from the 4-cell stage and more than 70% of eIF1A, U2AF, and PAP transcripts at 8-cell stage embryos were found to be synthesized de novo. Together, these data suggest that a minor EGA in buffalo embryos happens from 2- to 4-cell stages, while the major EGA takes place from 4- to 8-cell stage transition.
authors.affiliation: ABTC, National Dairy Research Institute, Karnal, Haryana, India.
authors.forename: A
authors.initials: A
authors.lastname: Verma
authors.forename: P
authors.initials: P
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Rajput
authors.forename: B
authors.initials: B
authors.lastname: Roy
authors.forename: S
authors.initials: S
authors.lastname: De
authors.forename: T K
authors.initials: TK
authors.lastname: Datta
mesh_terms: D053959:Alpha-Amanitin / Q000494:pharmacology; D000818:Animals; D001755:Blastocyst / Q000502:physiology*; D002020:Buffaloes / Q000196:embryology* / Q000235:genetics*; D046149:Embryo Culture Techniques; D004622:Embryo, Mammalian / Q000502:physiology; D015977:Eukaryotic Initiation Factor-1 / Q000235:genetics; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D009687:Nuclear Proteins / Q000235:genetics; D009865:Oocytes / Q000378:metabolism / Q000502:physiology; D011062:Polynucleotide Adenylyltransferase / Q000235:genetics; D012326:RNA Splicing / Q000235:genetics; D012261:Ribonucleoproteins / Q000235:genetics; D000072668:Splicing Factor U2AF
chemical_list: D053959:Alpha-Amanitin; D015977:Eukaryotic Initiation Factor-1; D009687:Nuclear Proteins; D012261:Ribonucleoproteins; D000072668:Splicing Factor U2AF; C026022:eukaryotic peptide initiation factor-1A; D011062:Polynucleotide Adenylyltransferase